Lexpos News

As announced in the NHS Primary Care bulletin (published 19 September 2024), from 1 January 2025, GP practices will be able to order the sub dermal contraceptive implant (Nexplanon® 68mg implant) directly from their suppliers and claim back the cost.  This will mean that patients do not have to go to the pharmacy to pick [...]

The post Changes to supply route for sub dermal contraceptive implants (Nexplanon®) appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Nicorandil 10mg tablets. MSN/2024/096 Tier 2 – medium impact Date of issue: 19th September 2024 There are limited supplies of nicorandil 10mg tablets until 30th September 2024. Nicorandil 20mg tablets remain available and can support increased demand. Alternative treatments for angina [...]

The post Medicine Supply Notification: Nicorandil 10mg tablets appeared first on Community Pharmacy England.

NHS England has this week sent out a further cascade message to NHS pharmacy contract teams for distribution to all pharmacies via email (this follows on from the initial message that was emailed on 24th June 2024) regarding post event messages on PharmOutcomes. The new cascade message highlights the actions that pharmacy owners who use [...]

The post ACTION: For pharmacy owners who use or have previously used PharmOutcomes appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (19/09/2024) announced the following list of price concessions for September 2024: Drug Pack size Price concession Amiloride 5mg tablets 28 £15.94 Benzoyl peroxide 5% / Clindamycin 1% gel 30 [...]

The post September 2024 Price Concessions 2nd Update appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Eldepryl 5mg Tablets (Orion Pharma (UK) Ltd) Drug alert number: EL(24)A/42 Date issued: 18 September 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines defect information notice for: Eldepryl 5mg Tablets (Orion Pharma (UK) Ltd) Company name: Orion Pharma (UK) Ltd Product name: Eldepryl [...]

The post MHRA Class 3 Medicines Recall: Eldepryl 5mg Tablets (Orion Pharma (UK) Ltd) appeared first on Community Pharmacy England.